Are you Dr. Rock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 508-856-1090Fax+1 508-856-1094
Summary
- Dr. Kenneth Rock, MD is a board certified pathologist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1980 - 1983- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1979 - 1979
University of Rochester School of Medicine and DentistryClass of 1978
Certifications & Licensure
MA State Medical License 1983 - 2025- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse me...Gulce Sari, Karthik Dhatchinamoorthy, Laura Orellano-Ariza, Lindsay M Ferreira, Michael A Brehm
Research Square. 2024-09-02 - GENETIC ABLATION OF THE C-TYPE LECTIN RECEPTOR CLEC2D INCREASES PERITONITIS MORTALITY, INFLAMMATION, AND PHYSIOLOGY WITHOUT DIMINISHING ORGAN INJURY.Allan E Stolarski, Jiann-Jyh Lai, Jiyoun Kim, Kenneth L Rock, Daniel Remick
Shock. 2024-09-01 - 12 citationsTumor immune evasion through loss of MHC class-I antigen presentation.Gulce Sari, Kenneth L Rock
Current Opinion in Immunology. 2023-08-01
Grant Support
- Immunobiology Of MHC Restriction Of T-CellsNational Institute Of Allergy And Infectious Diseases1996–2012
- Immunobiology Of CTL Responses To Exogenous AntigenNational Institute Of Allergy And Infectious Diseases2009–2011
- How Cell Death And Sterile Particulates Stimulate Inflammation And DiseaseNational Institute Of Allergy And Infectious Diseases2009–2011
- Mitigating Radiodermatitis By Blocking Il-1-Dependent Neutrophilic InflammationNational Institute Of Allergy And Infectious Diseases2008–2010
- Adjuvants And Toll-Like Receptors In Vaccine DevelopmentNational Institute Of Allergy And Infectious Diseases2007–2008
- Endogenous Adjuvants In Viral Immunity And VaccinesNational Institute Of Allergy And Infectious Diseases2004–2008
- Immunobiology Of CTL Responses To Exogenous AntigensNational Institute Of Allergy And Infectious Diseases1999–2008
- Immunobiology Of MHC Restriction Of T CellsNational Institute Of Allergy And Infectious Diseases1998–2008
- Project 4: Inducing Antigen Specific Tolerance Using APCSNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Ajuvants And Toll-Like Receptors In Vaccine DevelopmentNational Institute Of Allergy And Infectious Diseases2004–2006
- Immunobiology Of Antigen Presenting Cells In VivoNational Institute Of Allergy And Infectious Diseases2002–2006
- Antibody Immunotherapy To A Pro-Apoptotic Tumor AntigenNational Cancer Institute2002–2004
- Vaccine Strategies For Immunotherapy Of CancerNational Cancer Institute1999–2002
- Vaccine For CTL Immunity In Human Immunodeficiency VirusNational Institute Of Allergy And Infectious Diseases1997–1999
- Faseb Summer Conference--Lymphocytes And AntibodiesNational Institute Of Allergy And Infectious Diseases1998
- Mechanisms Of Antigen Presentation That Enhance ImmunogenicityNational Institute Of Allergy And Infectious Diseases1996–1998
- Mechanisms In The Genration Of Protective ImmunityNational Institute Of Allergy And Infectious Diseases1996–1998
- Vaccine For CTL Immunity In Human Immunodeficiency VirusNational Institute Of Allergy And Infectious Diseases1996
- Growth &Differentiation Of Immature T Cells &ThymomasNational Cancer Institute1996
- Mechanisms In The Genration Of Protective ImmunityNational Institute Of Allergy And Infectious Diseases1995–1996
- Immunobiology Of MHC Restriction Of T-CellsNational Institute Of Allergy And Infectious Diseases1993–1996
- Growth &Differentiation Of Immature T Cells &ThymomasNational Cancer Institute1992–1996
- Immunobiology And Structure Of TAP And Related MoleculesNational Institute Of General Medical Sciences1990–1996
- Vaccine For Control Immunity To Immunodeficiency VirusNational Institute Of Allergy And Infectious Diseases1994–1995
- Enhancing Vaccine ImmunogenicityNational Institute Of Allergy And Infectious Diseases1994
- Vaccine For CTL Immunity To Human Immunodeficiency VirusNational Institute Of Allergy And Infectious Diseases1991–1993
- Immunobiology Of MHC Restriction Of T CellsNational Institute Of Allergy And Infectious Diseases1990–1992
- Immunobiology And Structure Of TAP And Related MoleculesNational Institute Of General Medical Sciences1988–1989
- Immunobiology Of MHC Restriction Of T CellsNational Institute Of Allergy And Infectious Diseases1988–1989
- Surface Molecules Involved In T Cell FunctionNational Institute Of Allergy And Infectious Diseases1985–1987
